A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)

被引:0
|
作者
Sahebjam, Solmaz [1 ]
Forsyth, Peter [1 ]
Arrington, John [1 ]
Jaglal, Michael [1 ]
Tran, Nam D. [1 ]
Etame, Arnold B. [1 ]
Wicklund, Melissa [1 ]
Drury-Sibiga, Ali [1 ]
Long, Wendy [1 ]
Evernden, Brittany [1 ]
Gatewood, Tyra [1 ]
Macaulay, Robert [1 ]
Chinnaiyan, Prakash [2 ,3 ]
Yu, Michael [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Beaumont Hlth, Dept Radiat Oncol, Royal Oak, MI USA
[3] Oakland Univ, Sch Med, Royal Oak, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ATIM-18
引用
收藏
页码:30 / 30
页数:1
相关论文
共 50 条
  • [31] Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
    Arpa, Donatella
    Parisi, Elisabetta
    Ghigi, Giulia
    Cortesi, Annalisa
    Longobardi, Pasquale
    Cenni, Patrizia
    Pieri, Martina
    Tontini, Luca
    Neri, Elisa
    Micheletti, Simona
    Ghetti, Francesca
    Monti, Manuela
    Foca, Flavia
    Tesei, Anna
    Arienti, Chiara
    Sarnelli, Anna
    Martinelli, Giovanni
    Romeo, Antonio
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL
    Peters, Katherine
    Reardon, David
    Randazzo, Dina
    Dutton, Shelley
    Edwards, Ashley
    Lipp, Eric
    Herndon, James, II
    McSherry, Frances
    Desjardins, Annick
    Ranjan, Tulika
    Vlahovic, Gordana
    Friedman, Henry
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [33] A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Aregawi, Dawit
    Kreisl, Teri N.
    Innis, Ellen
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [34] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma
    Wuthrick, Evan J.
    Curran, Walter J., Jr.
    Camphausen, Kevin
    Lin, Alexander
    Glass, Jon
    Evans, James
    Andrews, David W.
    Axelrod, Rita
    Shi, Wenyin
    Werner-Wasik, Maria
    Haacke, E. Mark
    Hillman, Gilda G.
    Dicker, Adam P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02): : 369 - 375
  • [36] FINAL RESULTS FROM A PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA
    Lee, Eudocia
    Muzikansky, Alona
    Gerstner, Elizabeth
    Kuhn, John
    Reardon, David
    Nayak, Lakshmi
    Norden, Andrew
    Doherty, Lisa
    Stefanik, Jennifer
    Armitage, Julee
    LaFrankie, Debra
    Ruland, Sandra
    Vardam, Trupti
    Stokes, Deirdre
    Smith, Katrina
    McCluskey, Christine
    Gaffey, Sarah
    Batchelor, Tracy
    Jain, Rakesh
    Duda, Dan
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2017, 19 : 17 - 17
  • [37] RESULTS OF TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE BRAIN GLIOMA
    Javadinia, S.
    Anvari, K.
    Shahabadi, M.
    [J]. NEURO-ONCOLOGY, 2018, 20 : 232 - 232
  • [38] Phase I study of terameprocol in patients with recurrent high-grade glioma
    Grossman, Stuart A.
    Ye, Xiaobu
    Peereboom, David
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Supko, Jeffrey G.
    Desideri, Serena
    [J]. NEURO-ONCOLOGY, 2012, 14 (04) : 511 - 517
  • [39] HYPOFRACTIONATED EXTERNAL BEAM RADIATION WITH BEVACIZUMAB FOR THE TREATMENT OF RECURRENT HIGH GRADE GLIOMA - REPORT OF TWO CASES
    Gilheeney, S. W.
    Wolden, S.
    Dunkel, I. J.
    Khakoo, Y.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II74 - II74
  • [40] EARLY TUMOR VOLUME EVOLUTION ADAPTIVELY PREDICTS PATIENT-SPECIFIC RESPONSE AND PROGRESSION RISK TO RADIOTHERAPY, PEMBROLIZUMAB, AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA IN A PHASE I TRIAL
    Glazar, Daniel
    Brady, Rene
    Howard, Rachel
    Grass, Daniel
    Arrington, John
    Yu, Michael
    Raghunand, Natarajan
    Sahebjam, Solmaz
    Enderling, Heiko
    [J]. NEURO-ONCOLOGY, 2019, 21 : 63 - 64